Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Pre- and Post-National Coverage Determination (NCD) Hematologic Outcomes and Blood Utilization in Cancer Patients with Chemotherapy-Induced Anemia (CIA): Results From a Multicenter Chart Review.

David H. Henry, MD, Corey J. Langer, MD, FACP, R. Scott McKenzie, MD, Catherine Tak Piech, MBA, Mekré Senbetta, PharmD, Kathy L. Schulman, MA, Edward J. Stepanski, PhD

Blood (2009) 114 (22): 2491.

https://doi.org/10.1182/blood.V114.22.2491.2491

Published: 2009

Journal Articles

Pre- vs. Post-National Coverage Determination (NCD) Blood Utilization and Hemoglobin Values among Medicare Patients Treated with Erythropoietic-Stimulating Agents (ESAs) for Chemotherapy-Induced Anemia (CIA)

Tanya Burton, PhD, Kay Larholt, ScD, Elizabeth Apgar, MPH, Chris Pashos, PhD, Brahim Bookhart, MBA, MPH, Mitra Corral, MS, MPH, Catherine Tak Piech, MBA, R. Scott Mckenzie, MD

Blood (2008) 112 (11): 1301.

https://doi.org/10.1182/blood.V112.11.1301.1301

Published: 2008

Journal Articles

Patient-Reported Fatigue Scores in Cancer Patients with Chemotherapy-Induced Anemia Treated with Erythropoietic-Stimulating Agents (ESAs).

Tanya Burton, PhD, David Hoaglin, PhD, Kay Larholt, ScD, Elizabeth Apgar, MPH, Chris Pashos, PhD, Brahim Bookhart, MBA, MPH, Mitra Corral, MS, MPH, Catherine Tak Piech, MBA, R. scott McKenzie, MD

Blood (2008) 112 (11): 1304.

https://doi.org/10.1182/blood.V112.11.1304.1304

Published: 2008

Journal Articles

Hemoglobin Levels Prior to Blood Transfusions in Oncology Patients Receiving Chemotherapy and Erythropoiesis-Stimulating Agents (ESAs): Observational Data from the DOSE Registry.

Kay M. Larholt, ScD, Tanya Burton, PhD, Chris L. Pashos, PhD, Brahim K. Bookhart, MBA, MPH, Catherine Tak Piech, MBA, Scott R. McKenzie, MD

Blood (2007) 110 (11): 4019.

https://doi.org/10.1182/blood.V110.11.4019.4019

Published: 2007

Journal Articles

Impact of Limiting Erythropoiesis-Stimulating Agent Use for Chemotherapy-Induced Anemia on the United States Blood Supply.

Francis Vekeman, MA, Brahim K. Bookhart, MBA, MPH, Mei S. Duh, ScD, MPH, Scott R. McKenzie, MD, Patrick Lefebvre, MA, Catherine Tak Piech, MBA

Blood (2007) 110 (11): 2896.

https://doi.org/10.1182/blood.V110.11.2896.2896

Published: 2007

Journal Articles

Impact of Anemia on the Medical Cost of Injurious Falls in the Elderly.

Patrick Lefebvre, MA, Samir H. Mody, PharmD, MBA, Mei S. Duh, MPH, ScD, Richard C. Woodman, MD, Sharon Buteau, MA, Catherine Tak Piech, MBA

Blood (2005) 106 (11): 2238.

https://doi.org/10.1182/blood.V106.11.2238.2238

Published: 2005

Journal Articles

Dosing Patterns and Transfusion Use in Cancer Patients Treated with Erythropoietic Agents: Results of an Observational Study of over 8,000 Patients.

Antoine Gosselin, MA, Patrick Lefebvre, MA, Mei S. Duh, MPH, ScD, Scott R. McKenzie, MD, Samir H. Mody, PharmD, MBA, Catherine Tak Piech, MBA

Blood (2005) 106 (11): 3118.

https://doi.org/10.1182/blood.V106.11.3118.3118

Published: 2005

Journal Articles

Meta-Analysis of Impact of Epoetin Alfa Versus Darbepoetin Alfa on Blood Transfusion Requirements.

Patrick Lefebvre, MA, Erick Moyneur, MA, Marya Zilberberg, MD, FCCP, Mei S. Duh, MPH, ScD, Jyoti Aggarwal, MHS, Catherine Tak Piech, MBA

Blood (2005) 106 (11): 948.

https://doi.org/10.1182/blood.V106.11.948.948

Published: 2005

Journal Articles

Anemia in the Elderly and the Risk of Injurious Falls.

Mei S. Duh, MPH, ScD, Samir H. Mody, PharmD, MBA, Patrick Lefebvre, MA, Richard C. Woodman, MD, Sharon Buteau, MA, Catherine Tak Piech, MBA

Blood (2005) 106 (11): 1333.

https://doi.org/10.1182/blood.V106.11.1333.1333

Published: 2005

Journal Articles

Greater Area under the Hemoglobin Change Curve Is Associated with Improved Outcomes in Elderly Patients Receiving Epoetin Alfa for Chemotherapy-Related Anemia.

Scott R. McKenzie, MD, Mei S. Duh, MPH, ScD, Patrick Lefevbre, MA, John M. Fastenau, MPH, RPh, Catherine Tak Piech, MBA

Blood (2004) 104 (11): 3146.

https://doi.org/10.1182/blood.V104.11.3146.3146

Published: 2004

NARROW

Pre- and Post-National Coverage Determination (NCD) Hematologic Outcomes and Blood Utilization in Cancer Patients with Chemotherapy-Induced Anemia (CIA): Results From a Multicenter Chart Review.

Pre- vs. Post-National Coverage Determination (NCD) Blood Utilization and Hemoglobin Values among Medicare Patients Treated with Erythropoietic-Stimulating Agents (ESAs) for Chemotherapy-Induced Anemia (CIA)

Patient-Reported Fatigue Scores in Cancer Patients with Chemotherapy-Induced Anemia Treated with Erythropoietic-Stimulating Agents (ESAs).

Hemoglobin Levels Prior to Blood Transfusions in Oncology Patients Receiving Chemotherapy and Erythropoiesis-Stimulating Agents (ESAs): Observational Data from the DOSE Registry.

Impact of Limiting Erythropoiesis-Stimulating Agent Use for Chemotherapy-Induced Anemia on the United States Blood Supply.

Impact of Anemia on the Medical Cost of Injurious Falls in the Elderly.

Dosing Patterns and Transfusion Use in Cancer Patients Treated with Erythropoietic Agents: Results of an Observational Study of over 8,000 Patients.

Meta-Analysis of Impact of Epoetin Alfa Versus Darbepoetin Alfa on Blood Transfusion Requirements.

Anemia in the Elderly and the Risk of Injurious Falls.

Greater Area under the Hemoglobin Change Curve Is Associated with Improved Outcomes in Elderly Patients Receiving Epoetin Alfa for Chemotherapy-Related Anemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only